Literature DB >> 16465462

Kynurenic acid synthesis in bovine retinal slices--effect of glutamate agonists.

T Zarnowski1, M Bialek, R Rejdak, E Zrenner, A Junemann, Z Zagorski, T Kocki, W A Turski.   

Abstract

The purpose of the present study was to investigate the effect of glutamate agonists upon kynurenic acid (KYNA) production in bovine retinal slices. Quantitative analysis of newly synthesized KYNA was carried out using an HPLC system and detected fluorimetrically. Glutamate at the concentration of 0.01, 0.1 and 1 mM reduced KYNA synthesis in the retinal slices to 70% (p < 0.05), 35% (p < 0.01) and 23% (p < 0.001), respectively. The concentration of glutamate reducing production of KYNA by 50% (IC(50)) was 0.035 mM (0.02-0.06). Aspartate at the concentration of 0.01, 0.1 and 1 mM lowered KYNA synthesis in the retinal slices to 80% (p < 0.01), 57% (p < 0.001) and 43% (p < 0.001), respectively. In contrast, kainic acid (up to 5 mM), alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) (up to 1 mM) and 1-aminocyclopentane-trans-1,3-dicarboxylic acid (t-ACPD) (up to 3 mM) turned out to be ineffective in diminishing KYNA synthesis. These data demonstrate that glutamate, aspartate and N-methyl-D-aspartate (NMDA) inhibit KYNA synthesis in bovine retinal slices with different potency.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16465462     DOI: 10.1007/s00702-005-0423-0

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  29 in total

1.  High levels of extracellular glutamate are present in retina during neonatal development.

Authors:  M F Haberecht; D A Redburn
Journal:  Neurochem Res       Date:  1996-02       Impact factor: 3.996

2.  Fluorimetric micro-determination of kynurenic acid, an endogenous blocker of neurotoxicity, by high-performance liquid chromatography.

Authors:  K Shibata
Journal:  J Chromatogr       Date:  1988-09-09

3.  An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid.

Authors:  M N Perkins; T W Stone
Journal:  Brain Res       Date:  1982-09-09       Impact factor: 3.252

4.  The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications.

Authors:  C Hilmas; E F Pereira; M Alkondon; A Rassoulpour; R Schwarcz; E X Albuquerque
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

5.  Apoptotic cell death in the mouse retinal ganglion cell layer is induced in vivo by the excitatory amino acid homocysteine.

Authors:  P Moore; A El-sherbeny; P Roon; P V Schoenlein; V Ganapathy; S B Smith
Journal:  Exp Eye Res       Date:  2001-07       Impact factor: 3.467

6.  Dual effect of DL-homocysteine and S-adenosylhomocysteine on brain synthesis of the glutamate receptor antagonist, kynurenic acid.

Authors:  E Luchowska; P Luchowski; R Paczek; A Ziembowicz; T Kocki; W A Turski; M Wielosz; J Lazarewicz; E M Urbanska
Journal:  J Neurosci Res       Date:  2005-02-01       Impact factor: 4.164

7.  Impairment of brain kynurenic acid production by glutamate metabotropic receptor agonists.

Authors:  E M Urbanska; T Kocki; T Saran; Z Kleinrok; W A Turski
Journal:  Neuroreport       Date:  1997-11-10       Impact factor: 1.837

8.  Rat brain slices produce and liberate kynurenic acid upon exposure to L-kynurenine.

Authors:  W A Turski; J B Gramsbergen; H Traitler; R Schwarcz
Journal:  J Neurochem       Date:  1989-05       Impact factor: 5.372

9.  L-homocysteic acid selectively activates N-methyl-D-aspartate receptors of rat retinal ganglion cells.

Authors:  D Zhang; S A Lipton
Journal:  Neurosci Lett       Date:  1992-05-25       Impact factor: 3.046

10.  Kynurenic acid production in cultured bovine aortic endothelial cells. Homocysteine is a potent inhibitor.

Authors:  Katarzyna Wejksza; Wojciech Rzeski; Jolanta Parada-Turska; Barbara Zdzisinska; Robert Rejdak; Tomasz Kocki; Etsuo Okuno; Martyna Kandefer-Szerszen; Eberhart Zrenner; Waldemar A Turski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-02-10       Impact factor: 3.000

View more
  1 in total

1.  Neuroprotection by acetoacetate and β-hydroxybutyrate against NMDA-induced RGC damage in rat--possible involvement of kynurenic acid.

Authors:  Sebastian Thaler; Tomasz J Choragiewicz; Robert Rejdak; Michal Fiedorowicz; Waldemar A Turski; Maria Tulidowicz-Bielak; Eberhart Zrenner; Frank Schuettauf; Tomasz Zarnowski
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-06-08       Impact factor: 3.117

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.